ArticlesOral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering
Norata GD, Tokgözoğlu L
Journal: Eur Heart J
First published: November 8, 2023 DOI: 10.1093/eurheartj/ehad682
Norata GD, Tokgözoğlu L
Journal:Eur Heart J
First published: November 8, 2023 DOI: 10.1093/eurheartj/ehad682